Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Duseja

Showing results (211-220 of 386) with videos related to

Pageof 39
Sort By:
Addiction (Abingdon, England)|May 13, 2026
Health and economic impact of universal screening and management of alcohol use disorders in India: An economic modelling studyNeha Purohit, Shubhmohan Singh, Atul Ambekar, et al.
Virchows Archiv : an International Journal of Pathology|August 7, 2023
Clinical, histopathological, and immunohistochemical spectrum of hepatolithiasis: a tertiary care center-based study from north IndiaSangamitra Rajasekaran, Suvradeep Mitra, Mayur Parkhi, et al.
Journal of Gastroenterology and Hepatology|July 24, 2019
Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admissionTarana Gupta, Dibya Lochan, Nipun Verma, et al.
Journal of Hepatology|July 21, 2019
Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care settingRadha K Dhiman, Gagandeep S Grover, Madhumita Premkumar, et al.
Diabetes & Metabolic Syndrome|February 4, 2026
Performance of fibrosis-4 and NAFLD fibrosis score for screening liver fibrosis in Indian individuals with type 2 diabetes: a prospective cross-sectional studyNarendra Singh Choudhary, Mohammad Shafi Kuchay, Swapnil Dhampalwar, et al.
World Journal of Gastroenterology|November 30, 2016
Genetic polymorphism in <i>CD14</i> gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver diseaseShweta Kapil, Ajay Duseja, Bal Krishan Sharma, et al.
Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation|May 17, 2011
Comparison of 7 staging systems in north Indian cohort of hepatocellular carcinomaSanjay Sarma, Balkrishan Sharma, Yogesh Kumar Chawla, et al.
Indian Journal of Psychological Medicine|March 17, 2023
Multidisciplinary and Integrated Treatment for Substance Use Disorders and Hepatitis C in an Addiction Treatment Service in IndiaAbhishek Ghosh, Tathagata Mahintamani, Madhumita Premkumar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
Saroglitazar, a Dual PPAR α/γ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled AnalysisMohammad Shadab Siddiqui, Deven Parmar, Farheen Sheikh, et al.
Journal of Clinical and Experimental Hepatology|April 17, 2026
Nor-ursodeoxycholic Acid for Metabolic Dysfunction-associated Steatotic Liver Disease: Is There Enough Evidence for Clinical Use? A Critique of a Phase III Trial and Regulatory Endorsement of the DrugKaran Kumar, Vivek Saraswat, Ashish Kumar, et al.
Pageof 39

Showing results (211-220 of 386) with videos related to

Sort By:
Pageof 39
Addiction (Abingdon, England)|May 13, 2026
Health and economic impact of universal screening and management of alcohol use disorders in India: An economic modelling studyNeha Purohit, Shubhmohan Singh, Atul Ambekar, et al.
Virchows Archiv : an International Journal of Pathology|August 7, 2023
Clinical, histopathological, and immunohistochemical spectrum of hepatolithiasis: a tertiary care center-based study from north IndiaSangamitra Rajasekaran, Suvradeep Mitra, Mayur Parkhi, et al.
Journal of Gastroenterology and Hepatology|July 24, 2019
Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admissionTarana Gupta, Dibya Lochan, Nipun Verma, et al.
Journal of Hepatology|July 21, 2019
Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care settingRadha K Dhiman, Gagandeep S Grover, Madhumita Premkumar, et al.
Diabetes & Metabolic Syndrome|February 4, 2026
Performance of fibrosis-4 and NAFLD fibrosis score for screening liver fibrosis in Indian individuals with type 2 diabetes: a prospective cross-sectional studyNarendra Singh Choudhary, Mohammad Shafi Kuchay, Swapnil Dhampalwar, et al.
World Journal of Gastroenterology|November 30, 2016
Genetic polymorphism in <i>CD14</i> gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver diseaseShweta Kapil, Ajay Duseja, Bal Krishan Sharma, et al.
Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation|May 17, 2011
Comparison of 7 staging systems in north Indian cohort of hepatocellular carcinomaSanjay Sarma, Balkrishan Sharma, Yogesh Kumar Chawla, et al.
Indian Journal of Psychological Medicine|March 17, 2023
Multidisciplinary and Integrated Treatment for Substance Use Disorders and Hepatitis C in an Addiction Treatment Service in IndiaAbhishek Ghosh, Tathagata Mahintamani, Madhumita Premkumar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
Saroglitazar, a Dual PPAR α/γ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled AnalysisMohammad Shadab Siddiqui, Deven Parmar, Farheen Sheikh, et al.
Journal of Clinical and Experimental Hepatology|April 17, 2026
Nor-ursodeoxycholic Acid for Metabolic Dysfunction-associated Steatotic Liver Disease: Is There Enough Evidence for Clinical Use? A Critique of a Phase III Trial and Regulatory Endorsement of the DrugKaran Kumar, Vivek Saraswat, Ashish Kumar, et al.
Pageof 39